Premium
The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase‐polymerase chain reaction
Author(s) -
Noguchi Shinzaburo,
Aihara Tomohiko,
Nakamori Shoji,
Motomura Kazuyoshi,
Inaji Hideo,
Imaoka Shingi,
Koyama Hiroki
Publication year - 1994
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19940901)74:5<1595::aid-cncr2820740516>3.0.co;2-l
Subject(s) - lymph , axillary lymph nodes , medicine , immunohistochemistry , reverse transcriptase , lymph node , metastasis , pathology , breast carcinoma , reverse transcription polymerase chain reaction , messenger rna , breast cancer , polymerase chain reaction , biology , cancer , gene , biochemistry
Background. The development of a sensitive method for the detection of breast carcinoma micrometastases in axillary lymph nodes is reported. Methods. The method was based on amplification of MUCl mRNA, which encodes a core protein of polymorphic epithelial mucin, by a reverse transcriptase‐polymerase chain reaction (RT‐PCR). Total RNA, which was extracted from a breast carcinoma cell line (MCF‐7), primary breast carcinomas, and axillary lymph nodes, was subjected to analysis of MUCl mRNA expression by the RT‐PCR method. Results. MUCl mRNA expression was detected by RT‐PCR in MCF‐7 cells and in all 15 primary breast carcinomas but not in control lymph nodes taken from patients with benign diseases. A serial dilution study revealed that MUCl RT‐PCR was a very sensitive method, detecting one MCF‐7 cell per 1,000,000 lymph node cells. The detection sensitivity of MUCl RT‐PCR method was compared with that of immunohistochemical staining of an epithelial marker (polymorphic epithelial mucin). Fifty axillary lymph nodes were obtained from 15 patients with primary breast carcinomas, and metastasis in each lymph node was investigated by both methods. The immunohistochemical method demonstrated metastasis in nine lymph nodes, and MUCl mRNA was detected in all of them. Of the 41 lymph nodes that were diagnosed to be devoid of metastasis by immunohistochemistry, MUCl mRNA was expressed by 6 but not by the other 35, indicating the presence of micrometastases in these 6 lymph nodes that could be detected only by the MUCl RT‐PCR method. Conclusions. The MUCl RT‐PCR method is more sensitive than immunohistochemistry for the detection of micrometastases in axillary lymph nodes. This new method would be of practical value in selecting the patients at high risk for relapse from those who are histologically lymph node negative.